Philips bags FDA nod for next-gen CT platform
Aims to boost speed & precision in patient care
Aims to boost speed & precision in patient care
At the core of Verida is Spectral Precise Image technology paired with a third-generation Nano-panel Precise dual-layer detector and an AI-based deep learning reconstruction engine
IntraSight Plus enables confident decision-making and better patient care,” Philips said, emphasizing efficiency, simplicity, and precision
Designed for intense clinical environments, Rembra can handle up to 270 exams per day
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
Adjusted EBITDA increased by 12.3 per cent to $531 million, up from $516 million in the same period last year
The FDA’s review also revealed delays in Philips’ internal investigations, with 54 inquiries failing to meet targeted completion dates—23 of which were delayed by more than 100 days
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
Subscribe To Our Newsletter & Stay Updated